Riboflavin, which improves energy metabolism similarly to coenzyme Q10 (CoQ10), is effective in migraine prophylaxis. We compared CoQ10 (3 x 100 mg/day) and placebo in 42 migraine patients in a double-blind, randomized, placebo-controlled trial. CoQ10 was superior to placebo for attack-frequency, headache-days and days-with-nausea in the third treatment month and well tolerated; 50%-responder-rate for attack frequency was 14.4% for placebo and 47.6% for CoQ10 (number-needed-to-treat: 3). CoQ10 is efficacious and well tolerated.
机构:
Tabriz Univ Med Sci, Fac Nutr & Food Sci, Student Res Comm, Tabriz, IranTabriz Univ Med Sci, Fac Nutr & Food Sci, Student Res Comm, Tabriz, Iran
Dahri, Monireh
论文数: 引用数:
h-index:
机构:
Hashemilar, Mazyar
Asghari-Jafarabadi, Mohammad
论文数: 0引用数: 0
h-index: 0
机构:
Tabriz Univ Med Sci, Fac Hlth, Dept Stat & Epidemiol, Tabriz, Iran
Tabriz Univ Med Sci, Rd Traff Injury Res Ctr, Tabriz, IranTabriz Univ Med Sci, Fac Nutr & Food Sci, Student Res Comm, Tabriz, Iran